Bristol-Myers Beats Second-Quarter Estimates

Bristol-Myers Beats Second-Quarter Estimates

Bristol Myers trumps analysts’ estimates on strong sales of its cancer immunotherapy and cardiology drugs

By Staff Writer on Jul 24, 2014 at 2:30 pm EST

Bristol-Myers Beats Second-Quarter Estimates
comments powered by Disqus